| FOR IMMEDIATE RELEASE June, 25 2026 |
Contact: Sean Stevens Director of Marketing and Communications 760-327-6777 x 106 sean@uscap.org |
USCAP Shares Update on Giving and Pathology Forward
PALM SPRINGS, CA — USCAP is pleased to share an update on how philanthropic programs and giving opportunities are described across the organization.
As of May 1, USCAP no longer uses the USCAP Foundation name. This update is intended to clarify that philanthropic support has always been part of USCAP’s broader mission and work. The Foundation was not a separate external entity, and this change does not alter the programs, activities, or donor commitments previously associated with that name.
Going forward, Pathology Forward will represent USCAP’s annual giving community and the programs made possible through donor support. Advancement will serve as the internal department that supports and partners in this work.
This is a change in naming and public structure only. USCAP’s philanthropic purpose, priorities, and programs remain unchanged. Donor support will continue to be aligned with original intent.
Through Pathology Forward and other giving opportunities, contributions to USCAP help support education, research, global collaboration, travel awards, mentorship, and initiatives that strengthen the future of pathology.
Members, donors, and partners can learn more through the Donate section of the USCAP website:
Pathology Forward
https://uscap.org/pathology-forward/
What Your Support Funds
https://uscap.org/what-your-support-funds/
Ways to Give
https://uscap.org/ways-to-give/
USCAP is grateful for the continued generosity and engagement of the pathology community as we work together to advance the field.
About USCAP
The United States and Canadian Academy of Pathology is a member organization dedicated to advancing pathology through high-quality continuing medical education and translational research. USCAP’s diverse educational offerings and modern digital learning platforms support pathologists worldwide in improving practice and patient outcomes.